Sophie RENEAUME Email

Office Manager . Carthera

Current Roles

Employees:
35
Revenue:
$3.9M
About
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since 2010. The company's proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain. A Phase 1/2a clinical trial is underway in glioblastoma while the new treatment option could be suitable for a wide range of other indications, including Alzheimer's disease.
Carthera Address
Hopital Pitie Salpetriere
PARIS, null
FRA
Carthera Email